Clinical trials / NCT05712356
NCT05712356Phase 2Completed

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Study sponsor: Lisata Therapeutics, Inc. · LSTA

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-04-05Actual
Enrollment · participants66Actual
Source updated2026-09-28Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Terminated

+ After

Completed

Check registry source

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Incidence of adverse events

+ After

Measure: Number of Subjects Experiencing Any Adverse Event

Actual enrollment decreased by 1 participants

− Before

67 participants (actual)

+ After

66 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

18 Apr 2026

+ After

5 Apr 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Terminated

Check registry source